r-1415

Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.

DSR-141562 is a new compound that can be taken orally and has a specific ability to inhibit phosphodiesterase 1 (PDE1) in the brain. This compound exhibits a preference for inhibiting human PDE1B, with an IC50 value of 43.9 nM. It also shows moderate inhibition of human PDE1A (IC50 = 97.6 nM) and PDE1C (IC50 = 431.8 nM). DSR-141562 is particularly useful in the study of positive symptoms, negative symptoms, and cognitive impairments associated with schizophrenia.

Compound Fr14151, with CAS No. 4651-81-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14151 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14152, with CAS No. 1003-56-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14152 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14153, with CAS No. 14678-02-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14153 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14156, with CAS No. 89-71-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14156 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14159, with CAS No. 76429-73-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14159 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14157, with CAS No. 76523-24-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14157 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14158, with CAS No. 442517-33-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14158 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

SR14150 is a partial agonist of high-affinity NOP receptor.